A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.
Open Access
- 1 November 1993
- journal article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 7 (11) , 2110-2119
- https://doi.org/10.1101/gad.7.11.2110
Abstract
Mad is a basic-helix-loop-helix-zipper protein that heterodimerizes with Max in vitro. Mad:Max heterodimers recognize the same E-box-related DNA-binding sites as Myc:Max heterodimers. However, in transient transfection assays Myc and Mad influence transcription in opposite ways through interaction with Max; Myc activates while Mad represses transcription. Here, we demonstrate that Mad protein is induced rapidly upon differentiation of cells of the myeloid lineage. The Mad protein is synthesized in human cells as a 35-kD nuclear phosphoprotein with an extremely short half-life (t1/2 = 15-30 min) and can be detected in vivo in a complex with Max. In the undifferentiated U937 monocyte cell line Max was found complexed with Myc but not Mad. However, Mad:Max complexes began to accumulate as early as 2 hr after induction of macrophage differentiation with TPA. By 48 hr following TPA treatment only Mad:Max complexes were detectable. These data show that differentiation is accompanied by a change in the composition of Max heterocomplexes. We speculate that this switch in heterocomplexes results in a change in the transcriptional regulation of Myc:Max target genes required for cell proliferation.Keywords
This publication has 33 references indexed in Scilit:
- Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activityCell, 1993
- Biphasic effect of Max on Myc cotransformation activity and dependence on amino- and carboxy-terminal Max functions.Genes & Development, 1992
- Modulation of mRNA levels during human keratinocyte differentiationJournal of Cellular Physiology, 1992
- myc FUNCTION AND REGULATIONAnnual Review of Biochemistry, 1992
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992
- Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers.Genes & Development, 1992
- Nuclear targeting sequences — a consensus?Trends in Biochemical Sciences, 1991
- Down-regulation of LFA-1 Adhesion Receptors by C- myc Oncogene in Human B Lymphoblastoid CellsScience, 1990
- N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastomaCell, 1986
- c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cellsNature, 1985